Founded Year

2017

Stage

Acquired | Acquired

Total Raised

$5.47M

About Scanwell Health

Scanwell Health provides healthcare consumers and companies with at-home medical testing and instant results. Scanwell pairs proven diagnostics with patented computer vision technology to put testing into the hands of people, enabling quick detection of acute illnesses and convenient monitoring of chronic diseases. The company was first to receive FDA 510(k) clearance for an over-the-counter diagnostic smartphone application.On December 21st, 2021, Scanwell Health was acquired by BD. The terms of the transaction were not disclosed.

Scanwell Health Headquarter Location

800 Wilshire Blvd Suite 200

Los Angeles, California, 90017,

United States

775-233-7846

ESPs containing Scanwell Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Medical Devices Tech

Modern day smartphones come equipped with a number of features — like high-resolution cameras, accelerometers, microphones, and more — that can detect and quantify different physiological and digital biomarkers. Coupled with metadata like SMS patterns, app usage, call logs, and geotags, smartphones house vast troves of information valuable for screening, diagnosing, and monitoring disease.

Scanwell Health named as Leader among 12 other companies, including AiCure, Mindstrong, and Dental Monitoring.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Scanwell Health's Products & Differentiation

See Scanwell Health's products and how their products differentiate from alternatives and competitors

  • At-Home Urinary Tract Infection Test

    Test for Urinary Tract Infections (UTIs) from the comfort and safety of your home. Receive test results within minutes. Users have the option to complete a telehealth visit with a virtual provider for same-day treatment.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Scanwell Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Scanwell Health in 4 CB Insights research briefs, most recently on Mar 29, 2021.

Expert Collections containing Scanwell Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Scanwell Health is included in 6 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,684 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

4,593 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,833 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health IT

9,236 items

Scanwell Health Patents

Scanwell Health has filed 2 patents.

The 3 most popular patent topics include:

  • Medical tests
  • Autosomal recessive disorders
  • Blood tests
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/13/2020

Color space, Software testing, Medical tests, Autosomal recessive disorders, Rare diseases

Application

Application Date

11/13/2020

Grant Date

Title

Related Topics

Color space, Software testing, Medical tests, Autosomal recessive disorders, Rare diseases

Status

Application

Latest Scanwell Health News

Global Rapid Diagnostic Tests (RDTs) Market is expected to witness a CAGR of 4.5% from 2021 to 2026

Jul 5, 2022

Description: Rapid diagnostic tests or RDTs are simple-to-use procedures that provide results in less than 20 minutes. Unlike most standard diagnostic tests, which are required to be sent to a lab for analysis, RDTs are done and results are provided at the point-of-care. Rapid tests are most frequently used to diagnose infectious diseases, such as flu, malaria, HIV, and COVID 19, among others. High impact of COVID 19 fueled the demand for Rapid Diagnostic Tests Market The global rapid diagnostic tests market has experienced a positive impact due to the COVID 19 pandemic. Although the demand for RDTs specifically for the detection of SARS-CoV-2 during 2020 and 2021 increased exponentially, the pandemic showed a negative impact on the sales of RDTs for cancer screening, blood glucose, cardiac markers, and other infectious diseases, among others. However, there has been a significant development in the rapid diagnostic tests market during the last two years; some of these are listed below: In October 2021, the NIH Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts totalling $77.7 million for the development and manufacturing of 12 new rapid diagnostic tests for SARS-CoV-2; offering high performance and low-cost home and POC tests. In September 2021, LumiraDx, a next-generation POC diagnostics company, launched its LumiraDx SARS-CoV-2 Ag Surveillance Test in the US market, specifically for use at schools and workplaces; which allows simultaneous testing of up to five samples on a small and portable instrument, costing $4 per sample and delivering digital results within 12 minutes. In July 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS) has awarded a contract of $35.1 million to LightDeck Diagnostics, to scale-up the production capacity of LightDeck’s SARS-CoV-2 Ultra-Rapid Antigen and COVID-19 Total Antibody Tests. In March 2021, FUJIFILM Corporation announced the launch of its antigen testing kit – ‘FUJIFILM COVID-19 Ag Test’, for detecting SARS-CoV-2, which is developed by using highly-sensitive detection technology based on silver halide amplification. Collaborations and acquisitions to boost adoption and co-develop advanced solutions The rapid diagnostic tests market has witnessed a number of acquisitions by market players to either enhance the adoption of these tests or to co-develop advanced diagnostic tests. Some of the strategic initiatives that boost the adoption of RDTs are listed below: In April 2022, bioMérieux entered into an agreement to acquire Specific Diagnostics, a developer of rapid antimicrobial susceptibility test (AST) system. Rapid AST provides fast and accurate AST results while reducing the global antimicrobial resistance (AMR) burden caused by antibiotic resistant pathogens. In February 2022, Sorrento Therapeutics, Inc. acquired a majority ownership of Zhengzhou Fortune Bioscience Co., Ltd. (FortuneBio), a diagnostic product manufacturer and Sorrento’s exclusive OEM manufacturer for COVISTIX. With enhanced sensitivity in detecting the Omicron variant, COVISTIX is a rapid antigen detection test for SARS-CoV-2 and its major variants of concern (VOCs). In February 2021, Becton, Dickinson and Company collaborated with Scanwell Health, a provider of smartphone-enabled at-home medical tests, to develop an at-home rapid test for SARS-CoV-2 using Becton, Dickinson and Company’s antigen test and Scanwell Health’s mobile app. Competitive Landscape Analysis: Rapid Diagnostic Tests Market The rapid diagnostic tests market is marked by the presence of key players such as Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (US), and ACON Laboratories, Inc. (US), and others. Explore Detailed Market Research Insights on Global Rapid Diagnostic Tests Market @ https://meditechinsights.com/rapid-diagnostic-tests-rdts-market/ About Medi-Tech Insights: Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services. Contact Us:

Scanwell Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Scanwell Health Rank

  • When was Scanwell Health founded?

    Scanwell Health was founded in 2017.

  • Where is Scanwell Health's headquarters?

    Scanwell Health's headquarters is located at 800 Wilshire Blvd, Los Angeles.

  • What is Scanwell Health's latest funding round?

    Scanwell Health's latest funding round is Acquired.

  • How much did Scanwell Health raise?

    Scanwell Health raised a total of $5.47M.

  • Who are the investors of Scanwell Health?

    Investors of Scanwell Health include BD, SmartCityX, National Institutes of Health, Paycheck Protection Program, Y Combinator and 8 more.

  • Who are Scanwell Health's competitors?

    Competitors of Scanwell Health include Aural Analytics, Digital Diagnostics, Altoida, Dental Monitoring, Biospectal and 15 more.

  • What products does Scanwell Health offer?

    Scanwell Health's products include At-Home Urinary Tract Infection Test and 4 more.

  • Who are Scanwell Health's customers?

    Customers of Scanwell Health include Becton, Dickinson and Company, Lemonaid Health, Wake Forest Baptist Health, Chronic Renal Insufficiency Study and Foundation for Innovative New Diagnostics.

You May Also Like

Binah.ai Logo
Binah.ai

Binah.ai is the developer of a real-time vital signs measurement app that only requires a smartphone, laptop, or tablet camera. Its app supports iOS devices, Android mobile devices, and Windows laptops and desktops.

Healthy.io Logo
Healthy.io

Healthy.io is a mobile health company turning smartphone cameras into medical devices. Its first product, Dip.io, is a clinically approved home urinalysis kit that effectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan.

Biospectal Logo
Biospectal

Biospectal has developed a smartphone application and platform that allow instant and accurate blood pressure monitoring and managemenet.

M
Mindstrong

Mindstrong is a provider of solutions for the diagnosis and treatment of neuropsychiatric disorders through the power of AI and ubiquitous mobile technology. The platform delivers real-time, continuous digital biomarkers of mood and cognition, including measures of processing speed, attention, memory, and executive function.

Dental Monitoring Logo
Dental Monitoring

Dental Monitoring allows orthodontists and dentists to remotely follow the treatment of their patients. After downloading the DM app to their smartphones, patients follow the patented DM auto-scan procedure. DM AI technology then extracts from these scans the essential parameters desired by the practitioner and combines them with the 3D dental modelings captured at the beginning of treatment.

A
AiCure

AiCure is an AI and advanced data analytics company targeting the health care industry. AiCure uses AI to see, hear and understand how people respond to treatment across clinical trials and patient care. Clinically proven to accurately measure and modify patient behavior, AiCure’s technologies keep patients engaged and optimized to treatment, as well as assess treatment effectiveness.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.